Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial.

    Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes Care. 2008 Oct;31(10):1933-8. Epub 2008 Jul 7.PMID: 18606979 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term effect of diabetes and its treatment on cognitive function.

    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J.

    N Engl J Med. 2007 May 3;356(18):1842-52. Erratum in: N Engl J Med. 2009 Nov 5;361(19):1914. PMID: 17476010 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.

    [No authors listed]

    Ann Intern Med. 1996 Feb 15;124(4):379-88.PMID: 8554246 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Implementation of treatment protocols in the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes Care. 1995 Mar;18(3):361-76.PMID: 7555480 [PubMed - indexed for MEDLINE]Related articles

    6.

    Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

    Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV.

    Diabetes Care. 1999 Nov;22(11):1779-84.PMID: 10546007 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months.

    Wysocki T, Harris MA, Mauras N, Fox L, Taylor A, Jackson SC, White NH.

    Diabetes Care. 2003 Apr;26(4):1100-5.PMID: 12663580 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Diabetes. 1997 Feb;46(2):271-86.PMID: 9000705 [PubMed - indexed for MEDLINE]Related articles

    9.

    The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.

    Chase HP, Lockspeiser T, Peery B, Shepherd M, MacKenzie T, Anderson J, Garg SK.

    Diabetes Care. 2001 Mar;24(3):430-4.PMID: 11289463 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

    [No authors listed]

    Am J Med. 1991 Apr;90(4):450-9.PMID: 2012085 [PubMed - indexed for MEDLINE]Related articles

    14.

    Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment.

    Kramer L, Fasching P, Madl C, Schneider B, Damjancic P, Waldhäusl W, Irsigler K, Grimm G.

    Diabetes. 1998 Dec;47(12):1909-14.PMID: 9836523 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.

    Fanelli CG, Pampanelli S, Porcellati F, Rossetti P, Brunetti P, Bolli GB.

    Ann Intern Med. 2002 Apr 2;136(7):504-14.PMID: 11926785 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Adverse events and their association with treatment regimens in the diabetes control and complications trial.

    [No authors listed]

    Diabetes Care. 1995 Nov;18(11):1415-27.PMID: 8722064 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus.

    Widom B, Simonson DC.

    Ann Intern Med. 1990 Jun 15;112(12):904-12.PMID: 2187391 [PubMed - indexed for MEDLINE]Related articles

    19.

    Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

    J Pediatr. 2001 Dec;139(6):804-12.PMID: 11743505 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.

    Garg SK, Paul JM, Karsten JI, Menditto L, Gottlieb PA.

    Diabetes Technol Ther. 2004 Oct;6(5):589-95.PMID: 15628812 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data